Dyne Therapeutics

DYNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.201 B

$17.14 +0.12%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$446.20

Loss-making

Shares outstanding

186,746,431

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#73Arcutis BiotherapeuticsARQT$3.49B
#74Arcus BiosciencesRCUS$3.42B
#75Dyne TherapeuticsDYN$3.20B
#76uniQureQURE$3.14B
#77MBX BiosciencesMBX$2.98B

What if Dyne Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$161,898.51

Per share 9,446× higher

Bitcoin $1.74T

$9,326.31

Per share 544× higher

Nvidia $5.52T

$29,536.13

Per share 1,723× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Dyne Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.